Annexon, Inc.ANNX

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$3.64
Market cap
$731.7M
P/E
—
Revenue (TTM)
—
Net income
-$202.7M
Dividend yield
—
1-year total return
30.5%
Net margin
—
Revenue growth
—
Debt / equity
—

What Annexon, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$63.4M-$130.3M-$141.9M-$134.2M-$138.2M-$206.7M
Free cash flow-$53.6M-$107.8M-$122.8M-$121.3M-$118.0M-$186.5M

More on ANNX.

Figures from Annexon, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.